In neuroblastoma SH-SY5Y cells exposed to hyperglycemia, a condition known to increase GSK3β activity [119], melatonin exerted an inhibitory effect on the GSK3β signaling pathway, likely through the activation of its melatonin receptor [62]. Here, GSK3B is linked to neuroblastoma.